Pharma Companies Invest In US While India Still Depends On China For APIs
రచన: TodayTelugu Desk1 నిమిషాల చదువు1 చూపులు
“For decades, India built its reputation as the “pharmacy of the world” by manufacturing low-cost generic medicines that reached millions across Africa, Latin America, and Asia. But now, the industry appears determined to move beyond the image of being merely a low-cost generic supplier,” said Ravi Uday Bhaskar, former Director General of Pharmexcil
సంబంధిత వార్తలు
వ్యాఖ్యలు
వ్యాఖ్యలు రాయడానికి లాగిన్ చేయండి












